Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | PGK1 | P00558 | 9/20 | 0.48 |
| ▸ | PGK2 | P07205 | 9/20 | 0.48 |
| ▸ | ACP3 | P15309 | 2/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12606472 | 0.86 | PGK1 (0.48) | SMN1; SMN2PGK1PGK2ACP3GAA | |
| SCHEMBL23091688 | 0.83 | ACP3 (0.46) | SMN1; SMN2PGK1PGK2ACP3 | |
| SCHEMBL6429206 | 0.77 | ACP3 (0.52) | SMN1; SMN2PGK1PGK2ACP3CES2 | |
| SCHEMBL4287643 | 0.76 | ACP3 (0.55) | SMN1; SMN2PGK1PGK2ACP3 | |
| SCHEMBL9174132 | 0.73 | ACP3 (0.57) | SMN1; SMN2PGK1PGK2ACP3 | |
| SCHEMBL11307755 | 0.73 | SMN1; SMN2 (1.00) | SMN1; SMN2PGK1PGK2ACP3POLB | |
| SCHEMBL23884937 | 0.72 | MAPK14 (0.38) | SMN1; SMN2CES2CES1GAANPC1 | |
| SCHEMBL13512948 | 0.72 | PGK1 (0.44) | SMN1; SMN2PGK1PGK2ACP3 | |
| SCHEMBL3421056 | 0.71 | SMN1; SMN2 (0.56) | SMN1; SMN2PGK1PGK2ACP3 | |
| SCHEMBL11121515 | 0.71 | PGK1 (0.52) | SMN1; SMN2PGK1PGK2ACP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10129975-B1 | Liquid metal interfaces for flexible and reconfigurable electronics | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2018-11-13 | — | — | US | disclosed |
| CN-102459290-B | Electronic devices comprising novel phosphonic acid surface modifiers | 乔治亚州技术研究公司 | 2017-03-22 | — | — | CN | disclosed |
| US-9171961-B2 | Coating materials for oxide thin film transistors | POLYERA CORPORATION (US) | 2015-10-27 | — | — | US | disclosed |
| US-9171961-B2 | Coating materials for oxide thin film transistors | POLYERA CORPORATION (US) | 2015-10-27 | — | — | US | disclosed |
| US-9171961-B2 | Coating materials for oxide thin film transistors | POLYERA CORPORATION (US) | 2015-10-27 | — | — | US | disclosed |
| CN-104641471-A | Coating material for oxide thin film transistor | POLYERA CORP | 2015-05-20 | — | — | CN | disclosed |
| US-8846978-B2 | Electronic devices comprising novel phosphonic acid surface modifiers | IMPERIAL INNOVATIONS LTD. (GB) | 2014-09-30 | — | — | US | disclosed |
| US-8846978-B2 | Electronic devices comprising novel phosphonic acid surface modifiers | IMPERIAL INNOVATIONS LTD. (GB) | 2014-09-30 | — | — | US | disclosed |
| US-20140021465-A1 | Coating Materials for Oxide Thin Film Transistors | FLEXTERRA, INC. | 2014-01-23 | — | — | US | disclosed |
| US-20140021465-A1 | Coating Materials for Oxide Thin Film Transistors | FLEXTERRA, INC. | 2014-01-23 | — | — | US | disclosed |
| US-20120114974-A1 | ELECTRONIC DEVICES COMPRISING NOVEL PHOSPHONIC ACID SURFACE MODIFIERS | NATIONAL SCIENCE FOUNDATION | 2012-05-10 | — | — | US | disclosed |
| US-20120114974-A1 | ELECTRONIC DEVICES COMPRISING NOVEL PHOSPHONIC ACID SURFACE MODIFIERS | NATIONAL SCIENCE FOUNDATION | 2012-05-10 | — | — | US | disclosed |
| EP-2417142-A1 | ELECTRONIC DEVICES COMPRISING NOVEL PHOSPHONIC ACID SURFACE MODIFIERS | Georgia Tech Research Corporation (US) | 2012-02-15 | — | — | EP | disclosed |
| CN-102099941-A | Stable electrodes with modified work functions and methods for organic electronic devices | GEORGIA TECH RES INST | 2011-06-15 | — | — | CN | disclosed |
| US-20110114935-A1 | Stable electrodes with modified work functions and methods for organic electronic devices | GEORGIA TECH RESEARCH CORPORATION (US) | 2011-05-19 | — | — | US | disclosed |
| US-20110114935-A1 | Stable electrodes with modified work functions and methods for organic electronic devices | GEORGIA TECH RESEARCH CORPORATION (US) | 2011-05-19 | — | — | US | disclosed |
| EP-2304820-A1 | STABLE ELECTRODES WITH MODIFIED WORK FUNCTIONS AND METHODS FOR ORGANIC ELECTRONIC DEVICES | Georgia Tech Research Corporation (US) | 2011-04-06 | — | — | EP | disclosed |
| WO-2010115854-A1 | ELECTRONIC DEVICES COMPRISING NOVEL PHOSPHONIC ACID SURFACE MODIFIERS | GEORGIA TECH RESEARCH CORPORATION (US) | 2010-10-14 | — | — | WO | disclosed |
| WO-2010007081-A1 | STABLE ELECTRODES WITH MODIFIED WORK FUNCTIONS AND METHODS FOR ORGANIC ELECTRONIC DEVICES | GEORGIA TECH RESEARCH CORPORATION (US) | 2010-01-21 | — | — | WO | disclosed |
| WO-2010007081-A1 | STABLE ELECTRODES WITH MODIFIED WORK FUNCTIONS AND METHODS FOR ORGANIC ELECTRONIC DEVICES | GEORGIA TECH RESEARCH CORPORATION (US) | 2010-01-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110114935-A1 | Stable electrodes with modified work functions and methods for organic electronic devices | EPCAM, EMD, L1CAM | SMN1; SMN2 1249/4885PGK1 3140/4885PGK2 3522/4885 |
| US-20120114974-A1 | ELECTRONIC DEVICES COMPRISING NOVEL PHOSPHONIC ACID SURFACE MODIFIERS | EFNA1, PHOSPHO1, EPHA6 | SMN1; SMN2 3316/4885PGK1 546/4885PGK2 418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.